US 8148344
Compositions and methods for mediating RNAi in vivo
granted A61KA61K47/554A61K47/69
Quick answer
US patent 8148344 (Compositions and methods for mediating RNAi in vivo) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Apr 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K47/554, A61K47/69, A61P, A61P43/00